AlzeCure Pharma Competitors and Similar CompaniesClear all
AlzeCure Pharma's competitors and similar companies include Dizlin, Roche and BioArctic.
 AlzeCure Pharma AlzeCure Pharma is a company developing diagnostics and therapeutics for Parkinson’s, Alzheimer’s diseases, and related neurodegenerative disorders. |  Dizlin Dizlin Pharmaceuticals is a pharmaceutical research company developing treatments for Parkinson's disease. |  BioArctic BioArctic is a research-based biopharmaceutical company mainly focused on disease-modifying treatments and diagnostics for neurodegenerative diseases. | ||
Founding Date | Founding Date 2012 | Founding Date 2003 | Founding Date 1896 | Founding Date 2003 |
Type | Type Public | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations Huddinge, SE HQ | Locations Göteborg, SE HQ | Locations Stockholm , SE HQ | |
Employees | Employees 11 | Employees 6 | Employees 103,249 | Employees 107 |
Valuation ($) | Valuation ($) 14.9 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.3 b |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) CHF61.5b (FY, 2025) | Revenue (est.) kr2b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods CHF13.1b (FY, 2025) | Cost of goods kr59.2m (FY, 2025) |
Gross profit | Gross profit kr1.6m (FY, 2025) | Gross profit N/A | Gross profit CHF50.5b (FY, 2025) | Gross profit kr1.9b (FY, 2025) |
Net income | Net income (kr47.7m) (FY, 2025) | Net income N/A | Net income CHF13.8b (FY, 2025) | Net income kr1b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Dizlin
HQ
Göteborg, SE
Employees
6
Dizlin Pharmaceuticals is a pharmaceutical research company developing treatments for Parkinson's disease.
View company
Roche
HQ
Basel, CH
Employees
103,249
Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.
View companyBioArctic
HQ
Stockholm , SE
Employees
107
BioArctic is a research-based biopharmaceutical company mainly focused on disease-modifying treatments and diagnostics for neurodegenerative diseases.
View company